Flow cytometry in conjunctival impression cytology: a new tool for exploring ocular surface pathologies

Françoise Brignole-Baudouin1, Ann-Christin Ott, Jean-Michel Warnet

  • 1Laboratory of Toxicology, Faculty of Pharmaceutical and Biological Sciences, University of Paris-5 René Descartes, Paris, France.

Insights

Flow cytometry (FCM) offers a novel approach to analyze ocular surface cells, aiding in the diagnosis and understanding of conditions like Sjögren

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Flow cytometry (FCM) is a versatile technique increasingly applied beyond immunology and hematology.
  • Ocular surface investigations benefit from FCM for analyzing cell biology and pathophysiology.
  • Impression cytology enables non-invasive collection of ocular surface cells for FCM analysis.

Purpose of the Study:

  • To explore the application of FCM in analyzing ocular surface cells obtained via impression cytology.
  • To investigate pathways such as apoptosis, cell lineage, immune markers, cytokine production, drug resistance, and oxidative stress in ocular surface conditions.
  • To evaluate the utility of FCM in understanding ocular surface diseases and the effects of topical treatments.

Main Methods:

  • Conjunctival cells collected using non-invasive impression cytology.
  • Cells fixed and dissociated for subsequent processing.
  • Immunostaining followed by flow cytometry (FCM) analysis.

Main Results:

  • FCM analysis revealed inflammatory and apoptotic patterns in patients with dry eye disease (keratoconjunctivitis sicca).
  • Studies identified similar patterns in patients undergoing long-term antiglaucoma medication, even without clinical inflammation signs.
  • Confirmed the presence of inflammatory and apoptotic markers in ocular surface cells.

Conclusions:

  • Flow cytometry combined with impression cytology is valuable for studying ocular surface pathophysiology.
  • This technique aids in understanding conditions like Sjögren's syndrome, ocular allergy, and drug toxicity.
  • FCM facilitates large clinical trials, drug monitoring, and assessment of topical medication efficacy and safety.